Jia-Xu Zhang1, Xiao-Hui Liu2, Xin-Hui Xie3, Dan Zhao4, Mo-Shui Shan5, Xi-Liang Zhang6, Xiao-Ming Kong7, Hong Cui8. 1. Medical Psychology Division, Chinese PLA General Hospital & Medical School PLA, Beijing, China; Navy Fengtai Retired Cadres Sanatorium, Beijing, China. 2. Medical Psychology Division, Chinese PLA General Hospital & Medical School PLA, Beijing, China. 3. Medical Psychology Division, Chinese PLA General Hospital & Medical School PLA, Beijing, China; Department of Psychiatry, Anhui Mental Health Center, Hefei, Anhui, China; Department of Psychiatry, Shenzhen Key Laboratory of Psychological Health Center, No. 1080 Cuizhu Road, Luohu, Shenzhen, China. 4. Department of Psychology, Shaanxi Normal University, Xi׳an, China. 5. Medical Psychology Division, Chinese PLA General Hospital & Medical School PLA, Beijing, China; 215 Clinical Department, PLA Dalian Sanatorium, Dalian, Liaoning, China. 6. General Surgery Department, Navy General Hospital, Beijing, China. 7. Department of Psychiatry, Anhui Mental Health Center, Hefei, Anhui, China. 8. Medical Psychology Division, Chinese PLA General Hospital & Medical School PLA, Beijing, China. Electronic address: xxh.med@gmail.com.
Abstract
OBJECTIVE: To assess the effectiveness of mindfulness-based stress reduction (MBSR) for chronic insomnia and combined depressive or anxiety symptoms of older adults aged 75 years and over. DESIGN: A randomized, controlled, single-blind clinical trial. PATIENTS AND METHODS: Participants included 60 adults aged 75 years and over with chronic insomnia. Participants were randomly assigned to the eight-week MBSR group or the wait-list control group. Assessments using the Pittsburgh Sleep Quality Index (PSQI), Self-rating Anxiety Sale (SAS), and Geriatric Depression Scale (GDS) were taken at baseline and post-treatment. For each outcome measure, a repeated measures analysis of variance was used to detect changes across assessments. RESULTS: There was a significant time × group interaction for the PSQI global score (P = .006); the MBSR group had a decrease in the PSQI global score (Cohen׳s d = 1.12), while the control group did not (Cohen׳s d = -0.06). Among the PSQI components, there was a significant time × group interaction for daytime dysfunction (P = .048); Cohen׳s d of the MBSR group was 0.76, while Cohen׳s d of control group was -0.04. There was no significant time × group interaction for the SAS score (P = .116), while for the GDS there was a significant time × group interaction (P = .039); the Cohen׳s d value for the MBSR group was 1.20, and it was 0.12 for the control group. CONCLUSION: This study demonstrated that the MBSR program could be a beneficial treatment for chronic insomnia in adults aged 75 years and older.
RCT Entities:
OBJECTIVE: To assess the effectiveness of mindfulness-based stress reduction (MBSR) for chronic insomnia and combined depressive or anxiety symptoms of older adults aged 75 years and over. DESIGN: A randomized, controlled, single-blind clinical trial. PATIENTS AND METHODS: Participants included 60 adults aged 75 years and over with chronic insomnia. Participants were randomly assigned to the eight-week MBSR group or the wait-list control group. Assessments using the Pittsburgh Sleep Quality Index (PSQI), Self-rating Anxiety Sale (SAS), and Geriatric Depression Scale (GDS) were taken at baseline and post-treatment. For each outcome measure, a repeated measures analysis of variance was used to detect changes across assessments. RESULTS: There was a significant time × group interaction for the PSQI global score (P = .006); the MBSR group had a decrease in the PSQI global score (Cohen׳s d = 1.12), while the control group did not (Cohen׳s d = -0.06). Among the PSQI components, there was a significant time × group interaction for daytime dysfunction (P = .048); Cohen׳s d of the MBSR group was 0.76, while Cohen׳s d of control group was -0.04. There was no significant time × group interaction for the SAS score (P = .116), while for the GDS there was a significant time × group interaction (P = .039); the Cohen׳s d value for the MBSR group was 1.20, and it was 0.12 for the control group. CONCLUSION: This study demonstrated that the MBSR program could be a beneficial treatment for chronic insomnia in adults aged 75 years and older.
Authors: Tessa Barkan; Michael Hoerger; Autumn M Gallegos; Nicholas A Turiano; Paul R Duberstein; Jan A Moynihan Journal: J Altern Complement Med Date: 2016-03-31 Impact factor: 2.579
Authors: Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin Journal: J Clin Sleep Med Date: 2021-02-01 Impact factor: 4.062